Outcomes Rocket

Clean, accessible, and well-governed healthcare data is the foundation for better care and effective AI. In this episode, Erik Johnson, Vice President of Marketing at Harmony Healthcare IT, discusses how healthcare organizations can preserve, manage, and activate decades of clinical, financial, and operational data. He explains how a comprehensive data lifecycle strategy helps reduce legacy system costs, improve interoperability, and build a stronger foundation for AI adoption. Erik also shares marketing insights from both established brands and startups, emphasizing the value of brand equity and achieving product-market fit. He explores the potential of agentic AI to support clinical decision-making, reduce administrative burden for clinicians, and improve patient outcomes. Tune in to learn how a strong healthcare data strategy can prepare organizations for the future of AI-enabled care! Resources: Connect with and follow Erik Johnson on LinkedIn. Follow Harmony Healthcare IT on LinkedIn and explore their website! Listen to Harmony Healthcare IT's Health Data Talks podcast.

What happens when a hospital trusts a robot as much as one of its own team members? In this episode of Outcomes Rocket, Saul Marquez speaks with Sultan Mehrabi, CEO of Relay Robotics, and Craig Anderson, Vice President of Innovation at BayCare, about how autonomous delivery robots are transforming hospital operations through a collaborative innovation partnership. They explain how Relay robots safely transport lab samples, medications, and other critical items, allowing nurses and pharmacy staff to spend more time on direct patient care while maintaining a secure chain of custody and reliable delivery. The conversation highlights that successful healthcare innovation depends less on adopting AI for its own sake and more on solving real workflow problems through close collaboration, user adoption, and continuous improvement. They also discuss why reliability, trust, and seamless integration into hospital infrastructure are essential for autonomous robotics to become accepted by clinicians, patients, and health systems alike. Learn how one health system is using autonomous robotics to improve patient care, reduce staff workload, and redefine what successful healthcare innovation really looks like! Resources: Connect with and follow Sultan Mehrabi on LinkedIn. Follow Relay Robotics on LinkedIn and explore their website! Connect with and follow Craig Anderson on LinkedIn. Follow BayCare on LinkedIn and explore their website!

What if the next breakthrough in surgical robotics isn't happening in the operating room, but inside the blood vessels? In this episode, David Fischel, Chairman and CEO of Stereotaxis, shares how the company is pioneering robotic endovascular surgery through an integrated platform of robotics, proprietary catheters, and digital technologies. He explains why successful surgical robotics requires an entire ecosystem that seamlessly connects devices, software, imaging, and physician workflows. David also reflects on Stereotaxis' transformation through nearly a decade of investment in research and development, regulatory milestones, and commercialization. Together, we discuss how intelligent robotics could make complex cardiovascular and neurovascular procedures safer, more precise, and more accessible in the years ahead. Tune in to hear how Stereotaxis is redefining robotic intervention, why ecosystem thinking is critical for healthcare innovation, and what the future of intelligent surgery could look like for physicians and patients! Resources: Connect with and follow David Fischel on LinkedIn. Follow Stereotaxis on LinkedIn and explore their website!

What if prostate cancer could be treated without a single incision, and patients could be home having dinner with their families the very same day? In this episode, Tom Tamberrino, Chief Commercial Officer of Profound Medical, discusses how the company's MRI-guided TULSA-PRO technology is changing prostate treatment through incisionless, minimally invasive procedures. He explains how focused ultrasound, AI-assisted treatment planning, and real-time MRI guidance enable physicians to treat both prostate cancer and benign prostatic hyperplasia while allowing patients to return home the same day. Tom also explores how new Medicare reimbursement is making the technology financially viable for urology practices, potentially expanding access to MRI-guided care outside traditional hospital settings. He concludes by highlighting the importance of men's health advocacy and introducing LetsHuddle.org, a community designed to encourage open conversations about prostate health and mental well-being. Tune in to learn how MRI-guided focused ultrasound, AI-assisted treatment planning, and a patient-first approach are redefining prostate care, and why the future of surgery may involve no scalpel at all. Resources: Connect with and follow Tom Tamberrino on LinkedIn. Follow Profound Medical on LinkedIn and explore their website! Discover the Let's Huddle website!

Move faster without losing focus: why medtech innovation must balance agility, regulation, and patient needs. In this episode, Mike Stuedemann, Co-Founder and Principal Consultant at agilityIRL, discusses how medical device companies can use agile techniques to accelerate product development while maintaining FDA compliance. He explores the regulatory challenges surrounding AI-enabled devices, particularly as technologies continue to learn and evolve after launch. Mike also explains how AI can support quality and regulatory teams by identifying potential risks, flagging requirements for review, and reducing manual work without replacing human expertise. Finally, he shares why personalized medicine, responsible data use, and practical applications of "boring AI" can drive more meaningful innovation while keeping accessibility, affordability, and patient outcomes at the center. Tune in to learn how agile development, human oversight, and patient-centered innovation can help medtech companies navigate a rapidly changing industry! Resources: Connect with and follow Mike Stuedemann on LinkedIn. Follow agilityIRL on LinkedIn and explore their website. Listen to the Take5 IRL podcast here.

Advanced patient monitoring becomes more practical for ASCs when innovation is integrated, scalable, and built around real outpatient workflows. In this episode, Blake Tatum, Vice President of US Commercial for Medtronic Acute Care and Monitoring, and Mike Lessick, Vice President of Sales and Marketing, Patient Monitoring, and Life Support for Mindray North America, discuss how their expanded partnership is helping ambulatory surgery centers access hospital-level monitoring technology in a simpler, more affordable way. They explain how Medtronic technologies, including Nellcor™ SpO2 monitoring, Microstream™ capnography, BIS™ brain monitoring, and INVOS™ tissue oximetry, can be integrated into Mindray's ASC-focused monitoring platform. Blake highlights how the partnership reduces complexity, enables faster access to innovation, and provides ASCs with flexible options to scale technology over time. Mike shares how a single integrated platform can reduce cognitive load for clinicians, streamline purchasing and training, and support stronger connectivity with electronic medical records. Tune in to learn how integrated monitoring partnerships can help ASCs improve efficiency, support clinical quality, and prepare for the next wave of outpatient care. Resources: Connect with and follow Blake Tatum on LinkedIn. Follow Medtronic on LinkedIn and discover their website! Follow and connect with Michael Lessick on LinkedIn. Follow Mindray on LinkedIn and discover their website!

Burnout often does not happen all at once. For many leaders, it starts with small moments of drift away from their vision, voice, values, and vitality. In this episode, Kristi Huber, Founder of Perspective Shift Consulting, discusses how leaders can recognize and prevent leadership drift before it leads to burnout. Drawing from her own lived experience, she explains why high achievers are especially vulnerable to overcommitting, losing alignment, and operating on autopilot. Kristi introduces the Radical Clarity Compass as a practical framework for helping leaders and teams pause, reflect, and reconnect with what matters most. The conversation explores how greater self-awareness and intentional leadership can create healthier, more sustainable success. Tune in to hear how intentional pauses, clearer priorities, and stronger alignment can help leaders return to clarity, energy, and purpose! Resources: Connect with and follow Kristi Huber on LinkedIn and visit her website. Follow Perspective Shift Consulting on LinkedIn and explore their website.

Start earlier than you think: why proactive quality and regulatory planning can save medtech companies time, money, and costly remediation. In this episode, Joseph McGonnigal, Account Manager at Rook Quality Systems, discusses how medtech companies can build stronger quality management systems and better prepare for regulatory submissions. He explains how AI can help teams lay the foundation for high-quality documentation, while emphasizing that experienced professionals remain essential to review outputs, address technical details, and ensure compliance. Joseph also explores the growing regulatory complexity surrounding software-as-a-medical-device, AI-enabled technologies, and de novo submissions. Finally, he shares why startups should document decisions early, establish quality processes from the outset, and avoid waiting until regulatory issues become costly problems. Tune in to learn how early documentation, expert guidance, and proactive quality management can help medtech companies move toward regulatory approval with greater confidence! Resources: Connect with and follow Joseph McGonnigal on LinkedIn. Follow Rook Quality Systems on LinkedIn and explore their website!

From generic implants to patient-specific solutions: how additive manufacturing is expanding what is possible across medtech. In this episode, Anekant Jain, Manager, Polymer Technologies at EOS, discusses how industrial additive manufacturing is transforming healthcare by enabling the production of customized implants, prosthetics, dental devices, and other patient-specific technologies. He explains why additive manufacturing extends far beyond traditional 3D printing, requiring scalable production, qualified materials, reliability, and repeatable outcomes. Anekant also explores how advances in sensors, materials, and manufacturing are creating more responsive prosthetics with haptic feedback and stronger integration with the human body. Finally, he examines the barriers to broader adoption, including qualification processes, reimbursement, cost, and access, and explains why the industry must rethink what is possible rather than simply reproducing traditional solutions. Tune in to learn how additive manufacturing, customization, and cross-industry collaboration are pushing the boundaries of medical innovation! Resources: Connect with and follow Anekant Jain on LinkedIn.  Follow EOS on LinkedIn and explore their website at eos.info.

What separates companies that consistently grow from those that simply launch products? In this episode, Caitlin Mayer, Senior Director of U.S. Marketing for Medtronic's Acute Care & Monitoring business, shares the go-to-market principles that have helped her team build stronger customer partnerships, align cross-functional teams, and accelerate growth through portfolio-based marketing. Drawing on real-world experience leading commercialization strategies in one of healthcare's fastest-growing care settings, Caitlin explains why today's customers expect more than products. They expect solutions that improve workflows, deliver economic value, and solve meaningful operational challenges. She also shares the planning process her team uses to unite marketing, sales, clinical, and product teams around a single business objective, creating the alignment needed to execute consistently and drive measurable results. What you'll learn: 1. Why portfolio selling creates stronger customer partnerships than product-centric selling. 2. How customer insights should shape positioning, segmentation, and go-to-market strategy. 3. How cross-functional alignment creates better execution and measurable business results. 4. A practical framework for moving from product launches to sustainable revenue growth. About Caitlin Mayer: Caitlin Mayer is the Senior Director of U.S. Marketing for Medtronic's Acute Care & Monitoring business. With more than 15 years of experience in healthcare marketing, she specializes in customer-centered go-to-market strategy, cross-functional alignment, and building commercial programs that drive measurable growth. Resources: • Connect with Caitlin Mayer on LinkedIn • Follow Medtronic on LinkedIn • Explore the Medtronic website

As AI and software become embedded in more medical technologies, companies must balance the pressure to innovate quickly with the responsibility to protect patients. In this episode, Suzanne Levy Friedman, Partner at Honigman, discusses how medical device and digital health companies can navigate evolving FDA regulations and bring products to market more efficiently. She explains how regulatory counsel helps organizations determine whether products fall under FDA oversight, distinguish wellness technologies from regulated devices, and build effective commercialization strategies. Suzanne also explores the growing tension between rapid innovation, particularly in AI, and the FDA's responsibility to protect public health. Finally, she shares how clearer regulatory guidance and early legal involvement can help manufacturers avoid costly setbacks and better operationalize compliance. Tune in to learn how early regulatory planning can help medtech companies innovate responsibly, reduce risk, and bring valuable technologies to patients more efficiently! Resources: Connect with and follow Suzanne Levy Friedman on LinkedIn. Follow Honigman on LinkedIn and explore their website. Contact Suzanne at sfriedman@honigman.com.

In fast-moving technology markets, innovation only creates value when companies can connect it to real business outcomes and bring people along through change. In this episode, Danny Chu, VP of High Tech at Globant, shares what he is seeing at the intersection of AI, robotics, and medtech from the floor of DeviceTalks in Boston. He discusses how minimally invasive technologies are reshaping care delivery and why AI represents a major inflection point for both service providers and customers. Danny explains that successful adoption requires more than advanced technology, emphasizing change management, human safety, and measurable business outcomes such as revenue growth, cost reduction, and operational efficiency. He also highlights the importance of modeling edge cases before scaling automation and maintaining a people-first approach throughout technology transformation. Tune in to learn how leaders can approach AI and robotics with a stronger focus on people, outcomes, and long-term adoption. Resources: Connect with and follow Danny Chu on LinkedIn or reach out via email. Follow Globant on LinkedIn and explore their website.

Better clinical decisions require more than evidence; they also require the right information inside the physician's workflow at the moment it matters. In this episode, Dr. Brian Fengler, Co-Founder and Chief Medical Officer of EvidenceCare, explains how clinical decision support helps health systems improve patient care while addressing operational and financial challenges. He discusses how EvidenceCare integrates directly into EHR workflows to guide physicians, reduce administrative burden, improve revenue capture, and increase visibility into utilization and costs. Brian also explores how the BetterCare platform supports the patient journey through AdmissionCare, CareGauge, and Care Insights by providing real-time feedback on care variation and performance. Finally, he shares his perspective on how AI and ambient documentation are reshaping physician workflows and enhancing the patient experience. Tune in to learn how actionable data, workflow integration, and physician engagement can help health systems deliver better care while improving efficiency and financial performance! Resources: Connect with and follow Dr. Brian Fengler on LinkedIn.  Follow EvidenceCare on LinkedIn and explore their website. Listen to the BetterCare Podcast here

Medical technology is evolving faster than many manufacturers can adapt to, and falling behind can now happen in months rather than years. In this episode, Seth Rowan, Director of Business Development at Harmac Medical Products, discusses how AI, data integration, and digital transformation are reshaping medical device manufacturing. He explains why clean data is essential for successful AI adoption, how manufacturers can identify bottlenecks before they grow, and why companies need scalable manufacturing partnerships to bring single-use medical devices from design through commercialization. Tune in to learn how manufacturers can turn rapidly changing technology into practical solutions without losing sight of execution, quality, and scale. Resources: Connect with and follow Seth Rowan on LinkedIn. Follow Harmac Medical Products on LinkedIn and explore their website!

Touchless patient monitoring is making it easier to track patient health without adding more burden to clinicians. In this episode, Nayan Patel, Senior Vice President and General Manager of Transformation and Digital Health at Neteera, discusses how contactless patient monitoring can bridge care gaps and alleviate nurse burnout. Drawing on his extensive background as a healthcare CIO, Nayan emphasizes that new technology must actively solve workflow bottlenecks rather than adding tasks to a clinician's plate. He explains how Neteera's FDA-cleared, camera-free radar technology continuously tracks vital signs like heart and respiratory rates directly through bedding and clothing. Ultimately, by seamlessly integrating these passive alerts into daily routines, health systems can predict patient deterioration days in advance and smoothly transition toward virtual care models. Tune in to learn how touchless monitoring could shape the future of patient care! Resources: Connect with and follow Nayan Patel on LinkedIn. Follow Neteera on LinkedIn and explore their website.

AI and robotics are creating new possibilities in healthcare, but turning prototypes into real-world systems takes reliable data, timing, and production-ready infrastructure. In this episode, Stan Schneider, CEO of Real-Time Innovations, explains how RTI powers intelligent distributed systems across healthcare, robotics, autonomous vehicles, defense, and other highly regulated industries. He discusses why RTI acts as the "nervous system" for physical AI, connecting algorithms, sensors, and actuators to deliver the right data at the right time. Stan also explores why high-quality, usable data is the foundation of safe and effective AI, particularly in healthcare and robotics. The conversation covers FDA certification, production readiness, integrating AI into clinical workflows, and why human judgment remains essential in care decisions. Tune in to hear how RTI is helping healthcare innovators move from promising prototypes to real-world intelligent systems! Resources: Connect with and follow Stan Schneider on LinkedIn. Follow Real-Time Innovations on LinkedIn and explore their website!

Hard tissue robotics may be ready for a major leap forward, but only if the industry stops treating surgical robots as single-purpose robotic arms. In this episode, Yossi Bar, CEO and Founder of LEM Surgical, explores the next evolution of surgical robotics and why hard tissue innovation is just getting started. Drawing on nearly two decades in medical devices, he explains why hard tissue robotics has trailed soft tissue robotics and why system architecture matters more than hardware alone. Yossi breaks down the difference between a robotic arm and a true surgical humanoid, highlighting the roles of vision, proprioception, and multi-tool operation. He also shares how AI and humanoid-inspired, general-purpose robotic platforms could expand clinical capabilities and shape the future of surgery. Tune in to hear why the best part of surgical robotics may still be ahead! Resources: Connect with and follow Yossi Bar on LinkedIn. Follow LEM Surgical AG on LinkedIn and explore their website.

Robotics and automation are accelerating across healthcare, but scaling innovation still depends on having the right people in place. In this episode, Joe Solari, Managing Director at ZRG Partners, and Lori Prehar, Managing Director of Embedded Recruiting at ZRG, discuss how robotics, automation, and AI are transforming medtech, healthcare operations, and talent strategy. Joe explains how robotics can improve efficiency, reduce clinician burnout, and help healthcare organizations scale as automation expands. Lori shares why embedded recruiting has become an effective solution for companies navigating uncertain hiring needs and growth plans. They also explore the opportunities and risks of AI, including its impact on recruiting, compliance, security, and robotics. Tune in to hear how robotics, automation, AI, and flexible recruiting models are shaping the future of healthcare growth! Resources: Connect with and follow Joe Solari on LinkedIn Connect with and follow Lori Prehar on LinkedIn. Follow ZRG on LinkedIn and explore their website!

Pharma portfolios can create powerful opportunities, but without clear positioning, brands can end up competing with each other. In this episode, Lumanity's Jakub Kaczor, VP, Strategy Consulting, and Peter Smith, SVP, Strategy Consulting, discuss the complexities of portfolio positioning in the pharmaceutical industry. The guests explain that while a focused R&D strategy drives commercial growth and sustained innovation, it also creates a paradox where a company's own assets can end up competing against each other in the same disease area. To mitigate internal rivalry and maximize commercial potential, they advise companies to begin co-positioning early and follow a structured planning process, grounded in market reality. Ultimately, achieving portfolio success requires overcoming brand egos through a collaborative mindset, establishing clear governance under a dedicated portfolio owner, and designing strategies that anticipate the future competitive landscape. Tune in to learn how pharma teams can reduce internal competition, improve customer clarity, and build stronger portfolios that serve both patients and commercial goals! Resources: Connect with and follow Jakub Kaczor on LinkedIn. Connect with and follow Peter Smith on LinkedIn. Follow Lumanity on LinkedIn and explore their website! Learn more about this series we're doing with Lumanity here:  https://lumanity.com/commercialization-podcasts/

In an AI-driven market, technology may be easier to replicate, but the right people remain a true competitive advantage. In this episode, Mike Silverstein, Managing Partner of Healthcare IT and Life Sciences at Direct Recruiters, discusses what healthcare companies often get wrong when building their teams. He explains why leaders should value grit over impressive résumés, how passive candidates can strengthen an organization, and why healthcare requires patience, resilience, and industry understanding. Mike also shares how beginning his recruiting career during the 2008 financial crisis helped him develop the relationships and determination needed to navigate future challenges. He emphasizes that lasting success comes from authenticity, meaningful networks, and consistently putting people first. Tune in to learn how healthcare organizations can build teams capable of thriving through uncertainty, technological change, and continued industry disruption. Resources Connect with Mike Silverstein on LinkedIn. Follow Direct Recruiters on LinkedIn and explore their website. Email Mike at mike@directrecruiters.com

Medical technology is moving quickly, and the companies that succeed will be the ones that stay connected, think strategically, and solve the right problems. In this live episode from DeviceTalks Boston, Etienne Nichols, MedTech Guru at Greenlight Guru and host of the Global Medical Device Podcast, discusses the major shifts shaping the medical device industry. He shares insights on global regulatory harmonization, tougher funding conditions, the growing role of AI, and why data strategy matters more than ever. Etienne also explains why companies need to understand their true user population, challenge assumptions in product development, and prepare for a future where medical devices work together as connected systems. Tune in to learn how medical device companies can navigate change, use data more strategically, and build solutions that better serve users and the broader healthcare ecosystem! Resources: Connect with and follow Etienne Nichols on LinkedIn. Follow Greenlight Guru on LinkedIn and explore their website. Listen to the Global Medical Device Podcast here. 

Healthcare robotics is not just about replacing tasks; it is about helping people do safer, more meaningful work. In this episode, Spencer Krause, President and CEO of SKA Robotics, shares how his team applies robotics across industries like mining, construction, agriculture, and healthcare. He explains how robotics can support hospitals by handling repetitive or difficult work, from moving waste and controlled medications to helping address patient transport challenges. Spencer also discusses the realities of bringing robotics into healthcare, including stakeholder buy-in, HIPAA concerns, sterilization needs, FDA requirements, and long sales cycles. Tune in to learn how robotics can reduce burden, improve safety, and bring cross-industry innovation into healthcare. Resources: Connect with and follow Spencer Krause on LinkedIn. Follow SKA Robotics on LinkedIn and explore their website. Listen to Spencer Krause on The Robot Report podcast.

Neurology care is in high demand, but long waitlists and specialist shortages continue to delay access for millions of patients. In this episode, Elizabeth Burstein, CEO and Co-founder of Neura Health, shares how her personal experience with delayed neurological care inspired a more accessible, technology-enabled care model. She explains how Neura Health supports patients with chronic neurological conditions while helping neurologists and care teams work more efficiently. Liz discusses how AI, workflow automation, clinical decision support, and neurological data can expand specialist capacity and reduce administrative burden. She also explores how these innovations can improve access to high-quality neurological care. Tune in to learn how technology-enabled neurology care is helping make specialists more accessible without replacing the human side of medicine. Resources: Connect with and follow Elizabeth Burstein on LinkedIn.  Follow Neura Health on LinkedIn and explore their website. Reach out to Liz at Liz@NeuraHealth.co

MedTech companies invest heavily in acquiring customers, but many still lack a clear strategy for retaining, expanding, and learning from them. Fortunately,  SaaS and tech already solved this years ago through the creation of a commercial function called Customer Success. In this episode, Rupal Ayer, Senior Director of Customer Success at Solventum, discusses why Customer Success should become a formal business category in healthcare. He explains how combining customer experience with customer outcomes can strengthen retention, guide enterprise decisions, and improve commercial performance. Rupal also shares how Customer Success connects sales, marketing, and service around the customer journey while helping organizations move from transactional vendors to trusted advisors. And building a culture that translates customer reality into enterprise action. Tune in to learn how embedding the voice of the customer at the center of enterprise decision-making can improve business performance and create better experiences for clinicians and patients. Resources: Connect with and follow Rupal Ayer on LinkedIn. Follow Solventum on LinkedIn and explore their website.

Many patients with tremor are caught between medications that lose effectiveness and invasive procedures they may not be ready to pursue. In this episode, Deanna Harshbarger, CEO of Cala Health, discusses how non-invasive bioelectronic medicine is creating a new treatment pathway for patients with essential tremor. She explains how Cala's wearable therapy measures each patient's tremor, personalizes stimulation, and uses the peripheral nervous system to interrupt tremor-related signals. Deanna also shares how the company overcame regulatory, reimbursement, and access challenges while building an entirely new category of care. Tune in to learn how patient-centered design, perseverance, and personalized neurostimulation are expanding treatment options for people living with tremor. Resources: Connect with and follow Deanna Harshbarger on LinkedIn. Follow Cala Health on LinkedIn and explore their website. Watch the video to learn how Cala Therapy works: https://calahealth.com/product/how-taps-works/

Orthopedic procedures are increasingly moving to ambulatory surgery centers, but many navigation technologies remain too expensive, complex, or inefficient for that setting. In this episode, Nic Aldrich, Vice President of Marketing at OrthAlign, discusses how handheld navigation technology is making precision orthopedic care more accessible. He explains how OrthAlign helps surgeons reduce variability, execute patient-specific plans, and bring advanced technology into total hip, knee, partial knee, and revision procedures. Nic also shares how the newly cleared Lantern ASC system was designed specifically for surgery centers, balancing accuracy with cost, speed, and ease of use. Tune in to learn how smaller, more efficient technologies are helping expand access to precision orthopedic care. Resources: Connect with and follow Nic Aldrich on LinkedIn. Follow OrthAlign on LinkedIn and explore their website. Learn more about the Lantern ASC system here.

AI in medtech is most valuable when it supports better clinical decisions, not when it replaces clinicians. In this episode, Alexis Anderson speaks with Will Mauldin, Co-Founder and CEO of Rivanna Medical, live from DeviceTalks Boston. Will explains how Rivanna is bringing AI-enabled imaging to clinical settings where providers have traditionally relied on blind or manual procedures, beginning with epidural anesthesia guidance and expanding into fracture detection. He shares how the company's handheld spine guidance technology helps clinicians visualize the epidural space, use AI as a confirmation tool, and build confidence through consistent outcomes. Will also discusses broader medtech trends around AI, automation, connected devices, and robotics, along with funding challenges for mid-stage companies and Rivanna's upcoming FDA milestones. Tune in and learn how AI-enabled imaging can improve safety, reduce bottlenecks, and support clinicians in high-demand care environments. Resources Connect and follow Will Mauldin on LinkedIn. Follow Rivanna Medical on LinkedIn and explore their website.

Lung cancer biopsies are still being done blind more often than you'd think, leading to costly diagnostic errors. In this episode, Reza Khorasaninejad, Founder & CEO at LEADOPTIK, discusses how advances in photonics and metasurface engineering are enabling highly miniaturized imaging systems for minimally invasive procedures. These innovations aim to address a major challenge in lung cancer biopsies: a lack of imaging guidance that can lead to significant diagnostic errors. Early clinical pilots across multiple sites are demonstrating strong performance, with one hospital already converting into a paying customer. Looking ahead, the company is partnering with Stanford Medicine to develop AI-driven decision support tools to further improve diagnostic accuracy. Tune in to learn how next-generation imaging and AI are changing that reality and helping physicians hit the right target the first time! Resources: Connect with and follow Reza Khorasaninejad on LinkedIn.Follow LEADOPTIK on LinkedIn and explore their website!

Healthcare technology only matters when it makes care safer, more accessible, and easier to deliver at scale. In this episode, Adam McMullin, CEO of AvaSure, joins Saul to discuss how virtual care, ambient AI, and smart room platforms are transforming inpatient care. He explains how AvaSure creates a “cocoon of safety” around patients and care teams through capabilities such as fall prevention, violence reduction, and expanded access to specialty care. Adam emphasizes that lasting technology adoption depends on thoughtful clinical workflow design, nurse engagement, open architecture, and strong partner ecosystems. He also shares leadership lessons on values alignment and explains why health systems are increasingly scaling smart room technologies to address financial pressures, workforce shortages, and efficiency demands. Tune in and learn how proven technology, trusted partnerships, and aligned leadership can help health systems deliver safer, smarter care. Resources: Connect with and follow Adam McMullin on LinkedIn. Follow AvaSure on LinkedIn and explore their website!

MedTech innovation succeeds when bold ideas are matched with disciplined execution, strong teams, and a clear purpose. In this episode, James Corbett, transformational MedTech CEO and Board Advisor, joins Saul to share the leadership lessons, operating principles, and industry changes that have shaped his decades-long career. Drawing on experience leading companies including Boston Scientific, ev3, Alphatec Spine, CathWorks, and AVITA Medical, Jim explains why people and purpose are the foundation of lasting success in healthcare. He discusses the future of MedTech, including the creation of new clinical categories, the importance of operational excellence, and the growing role of AI in leadership and business transformation. Jim also shares why many organizations are underutilizing AI, how his AI command center captures decades of operating knowledge, and why great people remain the ultimate competitive advantage. Tune in and learn how purpose-driven leadership, operational discipline, and AI-enabled execution can help shape the next generation of MedTech innovation! Resources: Connect with and follow James Corbett on LinkedIn. Explore Jim Corbett AI!

The future of market access belongs to organizations that plan years in advance. In this episode, Steve Mather, Global Practice Lead of Strategy and Insight at Lumanity, explains why pharmaceutical companies must prepare now for major market access changes coming in Europe and beyond. He highlights that Joint Clinical Assessments for rare disease assets, beginning in 2028, will require earlier planning, stronger governance, and more integrated evidence-generation strategies. Steve also discusses the complexity created by varying country-specific care pathways, limited comparators, and the growing importance of real-world evidence in rare disease development. Across policy shifts like JCA, IRA, MFN, and new European pharmaceutical legislation, the central message is clear: organizations that anticipate earlier will be better positioned to succeed. Tune in to hear how the future of rare disease market access is being reshaped, and why companies that prepare earlier will have a major strategic advantage! Resources: Connect with and follow Steve Mather on LinkedIn. Follow Lumanity on LinkedIn and explore their website! Learn more about this series we're doing with Lumanity here:  https://lumanity.com/commercialization-podcasts/

AI is transforming medical robotics, but not in the ways many people expect. In this episode, KUKA Robotics USA's Silke Wendt, Global Marketing Medical Robotics, and Corey Ryan, Director of Medical Robotics, discuss how labor shortages, increasing quality demands, and growing interest in AI are shaping the future of medical robotics. While AI is becoming more prevalent in areas such as simulation, collision detection, and path planning, they emphasize that regulatory requirements limit its role in autonomous clinical decision-making. They also highlight KUKA's focus on quality, strategic partnerships, global expansion, and the development of new robotic platforms to support a growing range of medical applications. Tune in to hear how KUKA is navigating the opportunities and challenges of AI, automation, and innovation in healthcare robotics! Resources: Connect with and follow Silke Wendt on LinkedIn. Connect with and follow Corey Ryan on LinkedIn. Follow KUKA Robotics USA on LinkedIn and explore their website!

A non-invasive Alzheimer's therapy is moving closer to patients, and it could reshape how brain health is treated. In this episode, Christian Howell, CEO of Cognito Therapeutics, joins Saul live at DeviceTalks Boston to discuss how the company is advancing a novel Alzheimer's therapy that uses sensory stimulation through light, sound, and touch. He shares insights from Cognito's HOPE study, the largest non-pharmacologic clinical trial in neurodegenerative disease, involving 673 participants across 70 sites. Christian explains why a strong evidence strategy is essential not only for regulatory approval but also for reimbursement, clinical adoption, and patient access. He also reflects on leadership lessons centered on service, humility, humor, and the importance of aligning stakeholders across the healthcare ecosystem to improve Alzheimer's care. Tune in to hear how Christian Howell and Cognito Therapeutics are working to bring new hope, stronger evidence, and a more accessible path forward for Alzheimer's patients and families! Resources: Connect with and follow Christian Howell on LinkedIn. Follow Cognito Therapeutics on LinkedIn and explore their website.

Health economics is not just about reimbursement. It is about proving how a technology reduces the total cost of care. In this episode, Betty Tsai, President of Cardiology Services International, explains why medtech companies must think beyond existing CPT or MS-DRG codes when shaping their commercialization strategies. Speaking with Saul at the MedTech Innovator event, she highlights how health economics reveals the true cost of a patient journey, from initial admission through readmissions and long-term care. Betty explores how value-based care and CMS performance metrics are reshaping hospital revenue and influencing adoption decisions. She also discusses alternative reimbursement pathways, such as the New Technology Add-on Payment, and emphasizes that companies demonstrating both clinical and economic value are more attractive to providers and investors. Tune in and learn why proving economic value may be one of the most important steps in driving medtech adoption. Resources: Connect with and follow Betty Tsai on LinkedIn.

What started as a one-year break from surgery became a global medtech movement. In this episode, Dr. Dylan Attard, CEO and Co-founder of MedTech World, shares how his journey from surgical training to entrepreneurship led to the creation of MedTech World, now a global platform hosting events across Europe, Asia, the Middle East, and North America. What began as a single event in Malta has evolved into a multi-region ecosystem connecting startups, investors, and healthcare leaders. He highlights the strategic expansion into Florida, a growing yet underrecognized medtech hub, and emphasizes the importance of creating spaces where companies can raise capital and enter new markets. Dr. Attard also reflects on the personal “why” behind his work, sharing how exposure to cardiac innovations, especially after losing his father, reinforces the mission to accelerate life-saving technologies. Tune in to hear how Dr. Dylan Attard scaled MedTech World across continents, and the personal story driving his mission to accelerate life-saving innovation! Resources: Connect with and follow Dr. Dylan Attard on LinkedIn. Follow MedTech World on LinkedIn and explore their website!

Most pharma launch frameworks don't fail because they lack structure; they fail because they become rigid checklists that kill strategic thinking. In this episode, Lumanity's Business Development Director, Jeff Hart, and Launch Excellence Principal, Kirsty Tait, talk about how pharmaceutical companies can scale launch excellence as pipelines grow and complexity increases. Kirsty and Jeff explain that rigid, one-size-fits-all frameworks lead to inefficiency, slow decisions, and misalignment across global and local teams. Instead, organizations need a standardized operating system with built-in flexibility to tailor strategy by asset and market. Ultimately, success depends not just on process, but on strong governance, a single source of truth, and a winning culture that drives execution. If your launch process feels slow, inconsistent, or overly complex, this conversation will help you rethink how to scale without losing speed or impact. Resources: Follow Lumanity on LinkedIn and explore their website! Connect with and follow Kirsty Tait on LinkedIn. Connect with and follow Jeff Hart on LinkedIn. Take a look at the Launch Excellence Health Check here! Learn more about this series we're doing with Lumanity here: https://lumanity.com/commercialization-podcasts

What if the biggest barrier to better healthcare outcomes is… the blood draw itself? In this episode, Web Golinkin, President at Babson Diagnostics, discusses how his company is reinventing blood testing with a patient-friendly, fingertip-based system. He explains why traditional venipuncture drives anxiety and non-adherence, and how BetterWay improves both experience and outcomes. He also shares how automation and simplified workflows reduce operational burden and expand access points for care. Finally, he explores why patient experience is becoming the key competitive differentiator in ambulatory healthcare. Tune in to learn how rethinking a decades-old process could unlock better care, better business, and better patient engagement. Resources: Connect with and follow Web Golinkin on LinkedIn, visit his website, or reach out via email! Follow Babson Diagnostics on LinkedIn and explore their website! Learn more about BetterWay here!

Great medtech innovations win because patients actually use them. In this episode, Ken Nelson, Partner and Founder at Nelson Jennings Ventures, shares his journey from cardiac device sales at Boston Scientific to helping commercialize major players in cardiac monitoring, including iRhythm, BioTelemetry, and Bardy Diagnostics. He highlights how innovations such as wearable cardiac patches have transformed patient adoption and reshaped the monitoring market. Ken reflects on Medtech Innovator's impact in accelerating commercialization, partnerships, and investor readiness. He advises early-stage companies to leverage accelerators and industry events like Life Science Intelligence to strengthen their path to market and fundraising success. Tune in to hear how decades of experience in cardiac monitoring and startup scaling translate into practical advice for founders navigating commercialization and growth! Resources: Connect with and follow Ken Nelson on LinkedIn.

Simplifying the complex world of healthcare reimbursement. In this episode, Jason Considine, President of Experian Health, discusses shifting the industry's focus from denial management to denial prevention by leveraging AI at the point of registration. He discusses the implementation of the Patient Access Curator, a tool that automates insurance discovery and validation to reduce human error and administrative costs. He also explains how Experian leverages rich data assets, such as employment data, to help providers navigate new regulatory requirements, such as the OBBA. This episode explores the mission of leveraging advanced technology to eliminate administrative waste, enabling resources to be redeployed into direct patient care. Tune in to start from the start with denial prevention! Resources Connect with and follow Jason Considine on LinkedIn. Follow Experian Health on LinkedIn and explore their website.

AI is advancing rapidly in healthcare, but speed without governance can create serious clinical, legal, and enterprise-level risks. In this episode, Peter Bonis, MD, Chief Medical Officer at Wolters Kluwer Health, explores how his team is developing reliable, evidence-based AI tools to support frontline clinicians without compromising trust or safety. He explains why clinicians are adopting AI faster than health systems can govern it, creating risks like the rise of “shadow AI.” Peter highlights the importance of transparency, human oversight, and trusted source material in ensuring safe clinical decision support. He also discusses how even experts can be influenced by faulty AI output and why governance models must evolve with frontline input to keep pace. Tune in and learn how healthcare leaders can approach AI governance more responsibly while still supporting innovation at the point of care! Resources: Connect with and follow Dr. Peter Bonis on LinkedIn! Follow Walters Kluwer Health on LinkedIn and visit their website!

Most medtech startups fail before market. The ones that succeed? They plan for it from day one. In this episode, Amanda Helgeson, Business Development Manager at Forj Medical, discusses her work at the CDMO, which helps medtech startups navigate the critical transition from development to manufacturing. She notes that standout companies at Medtech Innovator pair meaningful clinical innovation with the passion and persistence needed to reach the market. Forj differentiates itself by integrating design and manufacturing early, helping companies avoid costly downstream issues. Her core message is to take a holistic, long-term approach, aligning product design, regulatory pathways, and reimbursement strategies from the outset while staying flexible to adapt. Tune in to learn how a holistic, future-focused approach can turn promising ideas into scalable medical devices! Resources: Connect with and follow Amanda Helgeson on LinkedIn. Follow Forj Medical on LinkedIn and explore their website!

Healthcare payments are often discussed as a transparency problem, but the deeper issue is structural fragmentation across contracts, claims, remittances, and workflows. In this episode, Ted Ferrin, Senior Vice President of Payments Innovation at Zelis, explains how the acquisition of Rivet is bringing provider-facing payment intelligence into Zelis's broader infrastructure. He discusses why achieving financial clarity between payers and providers has been so difficult due to fragmented systems and legacy technology. Ted highlights that true transparency goes beyond simply displaying data and requires meaningful, actionable insights. He also shares how tools like Claims Insights and Zap Edge embed intelligence into payment workflows to reduce rework, improve visibility, and create a smoother experience for providers, payers, and patients. Tune in and learn how better payment intelligence could help turn transparency from a buzzword into real operational trust! Resources: Connect with and follow Ted Ferrin on LinkedIn. Follow Zelis on LinkedIn and visit their website!

Healthcare is drowning in documentation and fragmented data, but what if the system worked for clinicians rather than against them? In this episode, Dr. Richa Gupta, Vice President of Care Transformation at Ambience Healthcare, explains how Ambience provides a layer of intelligence on top of electronic medical records to optimize clinician workflow and patient interactions. Ambience's ambient listening system captures physician-patient interactions, supports documentation, and ensures accurate coding and billing, boosting clinician satisfaction and reducing revenue leakage. ROI is driven by high clinician utilization, validated outcomes, and measurable improvements in documentation burden, coding accuracy, and physician retention. In 2026, Ambience is expanding across the full care continuum, including ambulatory, emergency, and inpatient settings, offering a platform that surfaces real-time insights and enhances patient care. Tune in to hear how Ambience is transforming physician workflows and delivering real ROI across the care continuum! Resources: Connect with and follow Dr. Richa Gupta on LinkedIn. Follow Ambience Healthcare on LinkedIn and visit their website!

Transformational medtech innovation needs more than a great idea. It needs the right engineering, clinical evidence, reimbursement strategy, and commercialization support to reach patients. In this episode, Peter Lewis, Executive Vice President of Business Development at Hydrix, joins Saul Marquez at the MedTech Innovator Radar Forum to discuss what it takes to bring complex, safety-critical medical devices to market. Peter shares Hydrix's evolution from its origins in Australia to becoming a global medical product development company supporting cardiac, surgical robotics, imaging, neurostimulation, and other advanced technologies. He highlights why clinician-led innovation is especially powerful, what distinguishes today's most promising medtech startups, and why AI, reimbursement, and human clinical evidence are now essential pillars for growth. Tune in to learn what medtech innovators need to consider early if they want to build solutions that truly change care. Resources: Connect with and follow Peter Lewis on LinkedIn or reach out via email. Explore the Hydrix website here!

Healthcare technology should quietly remove friction and reduce burden so clinicians can focus on what matters most: caring for patients in a more human way. In this episode, Lisa Gulker, Chief Nursing Officer at Oracle Health and Life Sciences, discusses how Oracle is rethinking healthcare technology by building AI directly into the foundation of its systems rather than layering it on as an afterthought. She explains how this approach can help clinicians spend less time in the chart, reduce workflow fragmentation, and make technology feel more seamless in the care experience. Lisa also shares how Oracle is applying these capabilities across providers, life sciences, and payers, creating opportunities to accelerate research, improve clinical trial matching, streamline prior authorization, and reduce administrative burden across the ecosystem. Throughout the conversation, she brings a nurse leader's perspective to a central question in healthcare innovation: how do we use technology to make care feel more human, not less? Tune in and learn how embedded AI could reshape the healthcare experience for clinicians, staff, researchers, payers, and patients alike! Resources: Connect with and follow Lisa Gulker on LinkedIn. Follow Oracle Health on LinkedIn and visit their website!

What happens when some of healthcare's most trusted workers are still operating outside the systems that document, reimburse, and scale care? In this episode, Colby Takeda, Co-Founder & CEO of Pear Suite, joins Saul Marquez live at ViVE to explore why community health workers are becoming a more essential part of the healthcare ecosystem. Drawing from his background in senior living and public health, Colby explains how Pear Suite helps community-based providers move beyond paper and spreadsheets with tools to document care, navigate credentialing and contracting, submit claims, and get paid for the value they deliver. The conversation also looks at Pear Suite's broader vision for connecting community-based organizations, health plans, and providers in a more coordinated system of care. Colby shares why AI should reduce administrative burden instead of replacing trusted relationships, how co-design with frontline workers has shaped the platform, and where he sees the biggest opportunity to make community-based care more sustainable and accessible at scale. Tune in to hear how community health workers are becoming more essential to the healthcare ecosystem, and how better infrastructure and smarter technology can make community-based care more sustainable and scalable. Resources: Connect with Colby Takeda on LinkedIn Learn more about Pear Suite Explore Pear Suite for Providers Follow Pear Suite on LinkedIn

Launching in pharma, especially for smaller organizations, is a complex, high-pressure marathon, and establishing Launch Excellence fundamentals early is essential for success. In this episode, Andrew Mooney and Laurence Cooper, Launch Excellence Experts at Lumanity, discuss the overwhelming complexity and pressure of pharma launches, especially for smaller or first-time organizations with limited experience, resources, and intense market expectations. They break down five essential fundamentals: insight-driven strategy, strong governance and decision-making, organizational alignment and culture, right-sized team capabilities, and timely resourcing, to help teams build a solid foundation for success. They emphasize the importance of focus and discipline, including defining a clear, winnable segment, building an early, realistic critical path, maintaining an integrated, cross-functional plan, and using honest KPIs and risk planning to avoid costly surprises. They also highlight how smaller organizations can outperform larger competitors by leveraging agility, ruthless prioritization, strong leadership, and early preparation to replace chaos and burnout with clarity, confidence, and control at launch. If you're preparing for a first or early pharma launch and feeling the pressure, this conversation offers a practical blueprint to help you focus, stay ahead of risks, and build the confidence needed to execute successfully! Resources: Connect with and follow Andrew Mooney on LinkedIn. Connect with and follow Laurence Cooper on LinkedIn. Follow Lumanity on LinkedIn and explore their website! Take a look at the 5 Fundamentals here.

Successful medtech commercialization requires founders to know what only they can do best, then bring in the right partners to help scale the rest. In this episode, Dan Purvis, Chairman and Co-Founder of Velentium Medical, joins Saul Marquez at the MedTech Innovator Radar Forum to discuss the evolution of complex medical device development. Dan explains how Velentium was designed to integrate engineering, firmware, mechanical design, cybersecurity, testing, and manufacturing under one roof to better support OEMs from development through production. He also reflects on how medtech innovation has matured, with more companies arriving at events with working technology, animal data, and clearer paths to human use. Finally, Dan emphasizes that successful commercialization requires founders to focus on their strengths, build expert teams, and delegate specialized work. Tune in and learn how medtech companies can move from promising technology to scalable, secure, and patient-impacting solutions. Resources: Follow Velentium Medical on LinkedIn and visit their website here. Connect with Dan Purvis on LinkedIn.

Most medtech startups don't fail because of bad technology; they fail because no one built the market for it. In this episode, Ken Nelson, Partner and Founder at Nelson Jennings Ventures, and Omar Khateeb, CEO of MarketCraft, share how judging at MedTech Innovator sharpens their perspectives as investors, operators, and mentors by exposing them to diverse expert insights across regulatory, reimbursement, and commercialization. They emphasize that medtech success today requires far more than a great product; founders must actively build market demand and prioritize commercialization early. A major mistake many startups make is assuming acquisition will come easily after FDA approval without demonstrating real market pull and adoption. Ultimately, the best founders balance conviction with coachability while leveraging ecosystems like MedTech Innovator to accelerate growth and de-risk their path. If you're building, investing in, or advising medtech companies, this conversation will challenge how you think about commercialization, growth, and what actually drives valuation! Resources: Connect with and follow Ken Nelson on LinkedIn. Connect with and follow Omar Khateeb on LinkedIn. Follow MarketCraft on LinkedIn and explore their website! Check out the State of Medtech podcast!

Hospitals already have rich patient data. The next step is turning that data into validated, timely insights that help clinicians respond before patients deteriorate. In this episode, Brian Tufts, President & CEO at Ambient Clinical Analytics, joins Saul Marquez at the MedTech Innovator Radar Forum to explore how software-as-a-medical-device is improving critical care workflows. Brian explains how the company, a Mayo Clinic spinout, built an FDA-cleared platform that combines clinical analytics, decision support, and workflow automation to help hospitals monitor complex patients. He highlights tools like Sepsis DART, which enable earlier detection and response by embedding hospital-specific protocols directly into workflows. Brian also underscores that AI in healthcare must be validated, structured, and carefully implemented, not left to unproven models making clinical decisions. Tune in to learn how hospitals can better leverage data to improve patient care in a thoughtful, reliable way. Resources: Connect with and follow Brian Tufts on LinkedIn. Follow Ambient Clinical Technologies on LinkedIn and explore their website here.

The future of medtech is built by the people who keep moving ideas from concept to care. In this episode, Tom Salemi, editorial leader, podcast host, and longtime medtech community builder behind DeviceTalks, shares how his path from community journalism eventually led him into healthcare reporting, medical devices, conferences, and podcasting. He reflects on discovering purpose in serving industry communities and launching DeviceTalks Weekly during the pandemic to keep conversations going when in-person events stopped. Tom also discusses the importance of continuing to move forward during career pivots and uncertain moments that require people to bet on themselves. He explains why DeviceTalks focuses on the people behind medical innovation and shares his excitement about advances in neuromodulation, stroke care, clot removal, and surgical robotics. Tune in to hear how community, persistence, and purposeful storytelling continue to move medtech forward. Resources: Connect with and follow Tom Salemi on LinkedIn. Explore the Device Talks website!